High-Mobility Group Box-1 and Liver Disease

Area of Science:

• Hepatology
• Immunology
• Molecular Biology

Background:

• High-mobility group box-1 (HMGB1) is recognized as a crucial protein in liver disease pathogenesis.
• Initially considered an architectural protein, HMGB1 is now understood to mediate inflammation and injury signaling.

Purpose of the Study:

• To review the multifaceted roles of HMGB1 in acute and chronic liver diseases.
• To elucidate the signaling pathways and molecular mechanisms involving HMGB1 in hepatic injury.

Main Methods:

• Literature review of studies investigating HMGB1 in liver injury models and human diseases.
• Analysis of HMGB1's function as a damage-associated molecular pattern (DAMP).
• Examination of HMGB1's interactions with receptors like RAGE and TLR4.

Main Results:

• HMGB1 actively participates in ischemia/reperfusion, sepsis, and drug-induced liver injury.
• HMGB1 is implicated in alcoholic liver disease, liver fibrosis, nonalcoholic steatohepatitis, and hepatocellular carcinoma.
• Posttranslational modifications of HMGB1 influence its hepatic effects.

Conclusions:

• HMGB1 is a central mediator in the pathogenesis of diverse liver conditions.
• Targeting HMGB1 signaling presents a potential therapeutic strategy for liver diseases.
• Understanding HMGB1 modifications is key to comprehending its complex role in liver health and disease.